Quick Search:       Advanced Search
Prediction value of sST2 for the prognosis of patients with immune checkpoint inhibitor-associated myocarditis
Received:February 28, 2021  Revised:April 07, 2021  Click here to download the full text
Citation of this paper:LI Zheng,WANG Yan,LIN Jin-yi,ZHAO Shi-hai,CHEN Jia-hui,ZHOU Yu-hong,LIU Tian-shu,DAN Bing,CHENG Lei-lei.Prediction value of sST2 for the prognosis of patients with immune checkpoint inhibitor-associated myocarditis[J].Chinese Journal of Clinical Medicine,2021,28(2):159-163
Hits: 1726
Download times: 424
Author NameAffiliationE-mail
LI Zheng Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
Shanghai Institute of Medical Imaging, Shanghai 200032, China 
 
WANG Yan Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
LIN Jin-yi Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China 
 
ZHAO Shi-hai Department of Radiodiagnosis, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
CHEN Jia-hui Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China 
 
ZHOU Yu-hong Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
LIU Tian-shu Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China  
DAN Bing Department of Medical Oncology, Dunfu Hospital, Shanghai 200032, China  
CHENG Lei-lei Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
Shanghai Institute of Medical Imaging, Shanghai 200032, China 
cheng.leilei@zs-hospital.sh.cn 
Abstract:Objective: To investigate the prognostic value of soluble growth stimulation expressed gene 2 protein (sST2) in patients with immune checkpoint inhibitor-associated myocarditis (ICIAM).Methods: From January 1, 2019 to December 31, 2020, 19 patients with ICIAM were selected from Cardio-oncology multidisciplinary team of Zhongshan Hospital, Fudan University. According to the prognosis, they were divided into the survival group (n=15) and the death group (n=4). Receiver operating characteristic (ROC) curve was used to analyze the predictive value of sST2 level for prognosis.Results: The peak concentration of sST2 in the death group was higher than that in the survival group during the treatment (156.50[91.60, 410.60] ng/mL vs 54.65[18.20, 97.40] ng/mL, P=0.014), and there was no significant difference in other indexes. The peak concentration of sST2 was negatively correlated with survival (r=-0.683, P=0.010). ROC analysis showed that when sST2 level was 87.5 ng/mL, area under the curve (AUC) was 0.967, sensitivity was 90.0%, and specificity was 100.0%.Conclusions: sST2 could predict the prognosis of patients with ICIAM, and could help to make and improve the treatment of patients with ICIAM.
keywords:soluble growth stimulation expressed gene 2 protein  immune checkpoint inhibitor  myocarditis
HTML  View Full Text  View/Add Comment  Download reader